Roche Holding AG (RHHBF)
OTCMKTS · Delayed Price · Currency is USD
333.00
0.00 (0.00%)
Aug 3, 2025, 8:00 PM EDT
United States Steel Market Cap
Roche Holding AG has a market cap or net worth of $270.68 billion as of August 4, 2025. Its market cap has increased by 15.92% in one year.
Market Cap
270.68B
Enterprise Value
304.03B
Revenue
79.83B
Ranking
n/a
PE Ratio
22.83
Stock Price
$333.00
Market Cap Chart
Since January 2, 1992, Roche Holding AG's market cap has increased from 8.76B to 270.68B, an increase of 2,990.36%. That is a compound annual growth rate of 10.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 4, 2025 | 270.68B | 19.65% |
| Dec 30, 2024 | 226.23B | -3.34% |
| Dec 29, 2023 | 234.04B | -9.76% |
| Dec 30, 2022 | 259.35B | -22.73% |
| Dec 30, 2021 | 335.62B | 12.23% |
| Dec 30, 2020 | 299.05B | 8.13% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.93M |
| Veradigm | 823.67M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 519.96M |
| Glass House Brands | 438.99M |
| American Oncology Network | 408.39M |
| Northwest Biotherapeutics | 376.73M |
| CytoDyn | 366.82M |